• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MedImmune

MedImmune

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Evotec and ex scientia Announce Partnership to Discover Bispecific Small Molecule Immuno-Oncology Therapeutics

    Evotec and ex scientia Announce Partnership to Discover Bispecific Small Molecule Immuno-Oncology Therapeutics

  2. Evotec and Pierre Fabre Sign Multi-Year Compound Management Agreement

    Evotec and Pierre Fabre Sign Multi-Year Compound Management Agreement

  3. Sosei Subsidiary Heptares and Kymab Enter Strategic Collaboration to Discover, Development and Commercialise Novel Antibody Therapeutics

    Sosei Subsidiary Heptares and Kymab Enter Strategic Collaboration to Discover, Development and Commercialise Novel Antibody Therapeutics

  4. OpportunityAnalyzer: Sjgren's Syndrome - Opportunity Analysis and Forecast to 2024 - Research and Markets

    OpportunityAnalyzer: Sjgren's Syndrome - Opportunity Analysis and Forecast to 2024 - Research and Markets

  5. Actor Wil Wheaton and They Might Be Giants Headline USA Science & Engineering Festival, Free Expo with 3,000 Hands-on Activities, Shows and Celebs

    Actor Wil Wheaton and They Might Be Giants Headline USA Science & Engineering Festival, Free Expo with 3,000 Hands-on Activities, Shows and Celebs

  6. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  7. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

  8. Morningstar Indexes: Weekly Market Report

    Week ending April 27: Quarterly earnings continue to boost market's spirits. 

  9. Services Super Sector: Major Themes

    Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.